Acute kidney injury - Nursing Case Study
Pathophysiology
• Primary mechanism: Acute kidney injury (AKI) often results from impaired blood flow to the kidneys, known as prerenal AKI. This can occur due to conditions like dehydration, heart failure, or blood loss, leading to inadequate perfusion and oxygen delivery to renal tissues, causing cellular injury.
• Secondary mechanism: Intrinsic AKI involves direct damage to the kidney tissues, commonly due to acute tubular necrosis (ATN). This can be triggered by prolonged ischemia or nephrotoxins (such as certain medications or contrast dyes), causing tubular cell death and obstruction.
• Key complication: Both mechanisms can lead to reduced glomerular filtration rate (GFR), resulting in the accumulation of waste products, electrolyte imbalances, and fluid overload. If unresolved, these issues can progress to chronic kidney disease or require renal replacement therapy.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Decreased urine output and swelling in lower extremities
• Key symptoms: Fatigue, nausea, mild shortness of breath, confusion
• Vital signs: Blood Pressure 160/95 mmHg, Heart Rate 98 bpm, Respiratory Rate 22 breaths per minute, Temperature 37.5°C, Oxygen Saturation 94% on room air
Section 1
As the healthcare team conducts an initial assessment of the 62-year-old male patient with suspected acute kidney injury, several key findings emerge. Upon physical examination, the patient's lower extremities exhibit significant pitting edema, indicating fluid overload, while auscultation of the lungs reveals bilateral crackles, suggesting pulmonary congestion. These findings align with the patient's complaint of mild shortness of breath and suggest that fluid retention is impacting respiratory function. Additionally, the patient appears lethargic and confused, which raises concerns about potential electrolyte imbalances or uremic encephalopathy.
Laboratory tests reveal critical insights into the patient's condition. Serum creatinine levels have risen sharply to 3.5 mg/dL from a baseline of 1.2 mg/dL, confirming a substantial decline in renal function. Blood urea nitrogen (BUN) is elevated at 50 mg/dL, and serum potassium levels are concerning at 6.0 mEq/L, indicating hyperkalemia. This electrolyte disturbance could contribute to the patient's confusion and poses a risk for cardiac dysrhythmias. Arterial blood gas analysis shows metabolic acidosis with a blood pH of 7.28 and decreased bicarbonate levels, reflecting the kidneys' inability to maintain acid-base balance.
Given these findings, the healthcare team prioritizes interventions focused on stabilizing the patient's hemodynamic status and addressing the electrolyte imbalances. Intravenous fluid therapy is cautiously initiated to improve renal perfusion, but closely monitored to avoid exacerbating fluid overload. The patient is also started on a low-potassium diet, along with medications such as sodium polystyrene sulfonate, to manage hyperkalemia. Continuous cardiac monitoring is employed due to the risk of arrhythmias. These measures aim to prevent further deterioration and stabilize the patient while the team investigates the underlying cause of the acute kidney injury.
Section 2
As the patient's condition is closely monitored, new diagnostic results reveal further complications. A follow-up serum electrolyte panel shows that despite initial interventions, the patient's potassium level remains elevated at 5.8 mEq/L, indicating persistent hyperkalemia. This necessitates the addition of intravenous calcium gluconate to stabilize cardiac membranes and prevent dysrhythmias. Furthermore, a repeat arterial blood gas analysis shows the metabolic acidosis has worsened slightly, with the blood pH now at 7.26 and bicarbonate levels further decreased. These findings suggest that the kidneys continue to struggle with waste elimination and acid-base balance.
Simultaneously, a chest X-ray is performed to assess the extent of pulmonary congestion. The imaging confirms significant bilateral pleural effusions, which correlate with the patient's increasing respiratory distress and decreasing oxygen saturation, now at 88% on room air. This necessitates the implementation of supplemental oxygen therapy and consideration of diuretic therapy to manage fluid overload, while balancing the risk of worsening renal perfusion.
The healthcare team is challenged to refine the treatment plan, weighing the benefits of aggressive fluid removal against the potential for further renal compromise. These developments prompt discussions around possible dialysis initiation, particularly if the patient's renal function and systemic status do not improve. The case underscores the complexity of managing acute kidney injury with concurrent complications, requiring careful coordination and clinical reasoning to optimize patient outcomes.
Section 3
As the healthcare team initiates the administration of intravenous calcium gluconate to address the persistent hyperkalemia, close monitoring of the patient's cardiac rhythm is prioritized. Continuous ECG monitoring reveals occasional premature ventricular contractions, suggesting that while the calcium is helping stabilize the cardiac membranes, the elevated potassium levels continue to pose a risk for dysrhythmias. Meanwhile, supplemental oxygen therapy is commenced via nasal cannula at 3 liters per minute, which slightly improves the patient’s oxygen saturation to 92%. However, the patient remains tachypneic, with a respiratory rate of 28 breaths per minute, indicating ongoing respiratory distress likely exacerbated by the bilateral pleural effusions.
In light of the worsening metabolic acidosis, with a pH of 7.26 and further decreased bicarbonate levels, the healthcare team decides to initiate a cautious diuretic regimen. Furosemide is administered intravenously to promote diuresis and alleviate fluid overload. The nurse carefully monitors the patient's urine output, blood pressure, and renal function tests to assess the response to the diuretic therapy. While initial results show a slight increase in urine output, blood pressure remains on the lower side, with a systolic reading of 100 mmHg, raising concerns about the balance between fluid removal and renal perfusion.
As these interventions progress, the team remains vigilant for any signs of new complications or further deterioration in renal function. The patient’s current status necessitates ongoing discussions regarding the potential need for dialysis, especially if renal function markers such as serum creatinine and glomerular filtration rate worsen. The healthcare team must continue to weigh the risks and benefits of each intervention, utilizing clinical reasoning to adjust the treatment plan in response to the dynamic nature of the patient’s condition. These considerations will guide the next steps in the management of this complex case of acute kidney injury with concurrent pulmonary and metabolic challenges.
Section 4
As the healthcare team continues to monitor the patient closely, new diagnostic results reveal a concerning trend in renal function. The patient's serum creatinine has risen to 3.5 mg/dL from a baseline of 2.8 mg/dL, and the estimated glomerular filtration rate (GFR) has decreased to 20 mL/min, confirming a further decline in kidney function. These lab results, coupled with persistent hyperkalemia, underscore the severity of the acute kidney injury. The patient's potassium level remains elevated at 6.2 mEq/L despite interventions, necessitating a reassessment of the current management plan.
In response, the healthcare team debates the timing and necessity of initiating dialysis. Given the patient's metabolic acidosis, deteriorating renal markers, and ongoing risk of life-threatening dysrhythmias, dialysis emerges as a more pressing consideration. However, the team must also consider the patient's hypotensive status, with blood pressure readings consistently around 95/60 mmHg, complicating the decision to proceed with aggressive fluid removal. Discussions focus on the potential use of continuous renal replacement therapy (CRRT) as a gentler alternative to conventional hemodialysis, which may offer better hemodynamic stability.
Amidst these deliberations, the patient's respiratory status further complicates the clinical picture. Despite supplemental oxygen, the patient remains tachypneic with oxygen saturation fluctuating between 90-92%. Repeat chest X-ray confirms worsening pleural effusions, contributing to impaired respiratory mechanics. The team evaluates the potential benefit of thoracentesis to alleviate respiratory distress, balanced against the risk of further destabilizing the patient. These complex considerations highlight the need for interdisciplinary collaboration and ongoing clinical reasoning to navigate the evolving challenges in this patient's care trajectory.
Section 5
As the healthcare team deliberates the best course of action, the patient's condition takes a concerning turn. A sudden change in vital signs is noted during routine monitoring: the patient's heart rate has increased to 120 beats per minute, with a blood pressure drop to 85/55 mmHg, indicating potential hemodynamic instability. The team quickly identifies signs of worsening metabolic acidosis, evidenced by a blood pH of 7.25 and bicarbonate level of 14 mEq/L. Additionally, the patient exhibits increased confusion and restlessness, suggesting possible uremic encephalopathy as renal waste accumulates.
In response to these developments, the team prioritizes correcting the severe hyperkalemia and acidosis. Calcium gluconate is administered to stabilize the cardiac membrane, and a combination of insulin and dextrose is given to drive potassium back into the cells. Despite these measures, the patient's potassium remains elevated at 6.0 mEq/L, and the refractory acidosis necessitates the initiation of bicarbonate therapy. Given the patient's persistent hypotension and risk of fluid overload, the team opts for continuous renal replacement therapy (CRRT) as a more hemodynamically stable approach to manage the acute kidney injury and associated complications.
The decision to initiate CRRT requires careful coordination with the nephrology and critical care teams. Meanwhile, the patient's respiratory status continues to decline, with oxygen saturation dropping to 88% despite high-flow oxygen support. The team urgently considers thoracentesis to relieve the pressure from pleural effusions, weighing the risks of procedural complications against the potential for improved respiratory function. This unfolding clinical scenario underscores the necessity of agile, evidence-based decision-making to address the multifaceted challenges presented by the patient's deteriorating condition.